# Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication

> **NCT07333001** · — · COMPLETED · sponsor: **Yueyue Li** · enrollment: 508 (actual)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS

## Interventions

- **DRUG:** 7-day triple therapy
- **DRUG:** 14-day dual therapy

## Key facts

- **NCT ID:** NCT07333001
- **Lead sponsor:** Yueyue Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-01
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-27
- **Target enrollment:** 508 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333001, "Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07333001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*